Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis


Dhami S., Kakourou A., Asamoah F., Agache I., Lau S., Jutel M., ...More

ALLERGY, vol.72, no.12, pp.1825-1848, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 72 Issue: 12
  • Publication Date: 2017
  • Doi Number: 10.1111/all.13208
  • Title of Journal : ALLERGY
  • Page Numbers: pp.1825-1848
  • Keywords: allergen immunotherapy, allergic asthma, cost-effectiveness, effectiveness, safety, HOUSE-DUST-MITE, DERMATOPHAGOIDES-PTERONYSSINUS EXTRACT, DOUBLE-BLIND TRIAL, STANDARDIZED SPECIFIC IMMUNOTHERAPY, GRASS-POLLEN IMMUNOTHERAPY, CAT-INDUCED ASTHMA, SUBLINGUAL IMMUNOTHERAPY, SEASONAL ASTHMA, PHARMACOLOGICAL-TREATMENT, ALTERNARIA-ALTERNATA

Abstract

BackgroundTo inform the development of the European Academy of Allergy and Clinical Immunology's (EAACI) Guidelines on Allergen Immunotherapy (AIT) for allergic asthma, we assessed the evidence on the effectiveness, cost-effectiveness and safety of AIT.